Demand for surgical sealants and adhesives is driven by the growing prevalence and incidence of various disorders such as obesity and CVDs, increasing incidence of trauma, growth in the number of accidents, rising need to manage blood loss in patients, growth in the number of surgeries, and rising geriatric population. In addition, the greater uptake of technologically advanced products and growing adoption of surgical sealants and adhesives in the U.S. and Europe (owing to FDA and CE Mark approvals) are responsible for driving the overall growth of this market.

The global surgical sealants and adhesives market is estimated to grow at a CAGR of 9.6% from 2016 to 2021 to reach USD 2.96 Billion by 2021.

Please provide your specific interest in this report so as to help you better, Download PDF Brochure @ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38230314

Lack of reimbursements, extensive clinical data requirements for product approvals, and high cost of these products may hinder the growth of this market to a certain extent during the forecast period. Emerging markets such as China, India, and Brazil offer significant opportunities for the growth of the market. However, relatively lower disposable income and lack of awareness in these regions may negatively impact the market growth.

The report analyzes the surgical sealants market by product, indication, application, and region. On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further divided into type and origin. On the basis of type, the natural/biological sealants segment is categorized into polypeptide/protein-based and polysaccharide-based sealants and adhesives. On the basis of origin, the natural/biological sealants and adhesives segment is divided into human blood and animal-based adhesives.

Moreover, the polypeptide/protein-based sealants consist of fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants comprise of chitosan-based and other polysaccharide-based adhesives. The synthetic and semi-synthetic sealants and adhesives market is segmented into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives. On the basis of indication, the market is segmented into surgical hemostasis, tissue sealing, and tissue engineering. Based on application, the market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.

Please provide your specific interest in this report so as to help you better, Download PDF Brochure @ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38230314

Geographical Region Covered in Report

In 2015, North America dominated the surgical sealants market followed by Europe, Asia-Pacific, and the Rest of the World. The major factors responsible for driving the growth of the market are the presence of many large hospitals and increasing number of surgical procedures being performed annually, a large number of major global players are based in the North American region, rising geriatric population and the growing prevalence of lifestyle diseases such as obesity and CVDs in the region. On the other hand, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period. This can be mainly attributed to the increasing investments by major players in these regions, rising health awareness, growing per capita income, increasing medical tourism, the presence of less stringent regulations, and growing demand for quality healthcare.

Market Key Players

The global market is characterized by the presence of a large number of players. Amidst intense market competition, major players are continuously focusing on achieving higher market shares through gaining regulatory approvals and acquisitions in the market. The global surgical adhesives market is consolidated in nature and is dominated by Baxter International, Inc. (U.S.), Johnson & Johnson (Ethicon, Inc.; U.S.), CryoLife, Inc. (U.S.), C. R. Bard, Inc. (U.S.). Other players include Medtronic plc (U.S.), Sanofi Group (France), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (U.S.), Ocular Therapuetix, Inc. (U.S.), Vivostat A/S (Denmark), and Sealantis, Ltd. (Israel).

Get More Information @ http://bit.ly/2rwpv3R